INTRODUCTION
Interest in the costs related to smoking has never been higher. Previous research has looked at the cost borne by taxpayers to treat people with smoking-related diseases under Medicaid. For the first time, we use these methods to look at the costs to Medicare, which covers the medical expenses of 34 million Americans age 65 or over and 5.5 million persons with disabilities. The numbers are significant: 16 percent of Medicare enrollees in 1994 reported themselves as current smokers, and another 44 percent reported themselves as former smokers (Olin and Liu, 1998) .
The published literature during the past three decades abounds with estimates of the annual costs of smoking in the United States (Hedrick, 1971; Luce and Schweitzer, 1978; Kristein, 1977; Rice et al., 1986; Office of Technology Assessment, 1985 and Bartlett et al., 1994) . Several studies include only the direct medical care costs; others include the indirect costs, the value of unpurchased resources lost attributable to smoking. These studies yield national cost estimates. Recently, two articles were published that presented State-level estimates of Medicaid smoking-attributable expenditures (SAEs) (Miller et al., 1998a) and total SAEs (Miller et al., 1998b) .
In this article, we present State estimates of Medicare expenditures attributable to smoking for the Medicare population, including those with disabilities. Estimates are reported by type of expenditure. Also presented are the Medicaid, residual public and private, and total SAEs for each State. Presentation of these State estimates enables each State to quantify its financial burden of smoking by source of payment.
METHODS
The estimation of Medicare SAEs involved four steps: (1) a national model of Medicare SAEs was estimated; (2) the national model was applied to the States; (3) a national estimate was derived from the sum of the State estimates; and (4) interval estimates from the national model were applied to the State estimates.
National Model
We estimated the Medicare expenditure models with data from respondents who were age 65 or over in the National Medical Expenditure Survey (NMES) (Agency for Health Care Policy and Research, 1991) . The model has three parts: a sample-bias correction equation; two morbidity equations estimating the effect of smoking history on smoking-related diseases and poor health status; and six expenditure equations estimating the effect of health status and smoking history on the likelihood of three different types of expenditures and on their positive magnitudes. Although there are separate models by sex, we shall refer to these models in the singular. We discuss these three parts in turn. A more detailed description of the national model and its estimation is contained in the Technical Note.
Sample Bias
There may be sample-selection bias introduced by the fact that the NMES obtained data on smoking history through its supplemental survey, which was conducted approximately 4 1 / 2 months into its annual study. Not every NMES respondent completed the survey. For example, participants who died in the first quarter did not participate. Any bias in participating would reflect two countervailing tendencies. First, the likelihood that people who were more concerned about health issues, and hence were more likely to participate in the supplemental survey, were likely to have a higher demand for medical services. Second, participants who were sicker and needed more medical services were less likely to participate. Bias is likely to occur in the estimation of ambulatory care, which is more likely a function of demand (i.e., discretionary) than for hospital or home health care, where services are more determined by supply than demand.
Morbidity
The morbidity portion of the model estimates the effect of smoking history (current, never smokers, or former/unknown smoking status) on previous disease and the effect of smoking history and the propensity for previous disease on selfreported poor health status. The first morbidity equation explains the propensity of a NMES participant (in the supplemental survey) ". . . to have previously been told by a doctor" that he or she had any of five diseases (cancer, emphysema, heart conditions, arteriosclerosis, and stroke) that proxy for the broad class of smoking-related diseases discussed in the Surgeon General's Reports (Centers for Disease Control, 1989) . The second equation estimates the propensity for poor health as a function of the propensity to have previously had a smoking-related disease. Health is self-reported as excellent, good, fair, or poor. There is a measurement error associated with the previous smokingrelated disease measure and the selfreported health measure, because smoking is not known to be related to all cancers. For example, skin cancer, the most prevalent form of cancer, is not known to be influenced by smoking.
Expenditures
Two Medicare expenditure equations were estimated for each of three types of medical expenditures: ambulatory, hospital, and home health expenditures. For each type, the first equation is a probit equation estimating the propensity for positive Medicare expenditures. The second equation is a log expenditure equation estimating the logarithm of the magnitude of expenditures, given expenditures were positive. Each equation was specified as a function of a participant's expected propensity for self-reported poor health status, conditional on their reported poor health status, and smoking history, controlling for sociodemographics, economic variables, and other risk factors.
SAEs and Smoking Attributable Fractions
SAEs are the difference between predicted expenditures for smokers and predicted expenditures for a hypothetical group of non-smoking smokers, i.e., nonsmokers who are similar to the smokers in every way except smoking status. The Medicare smoking-attributable fraction (SAF) is the ratio of smoking-attributable Medicare expenditures to total Medicare expenditures. The change in smoking status affects the expected propensity to have a smoking-related disease and expected health status, both of which in turn affect expected expenditures. Although health status and prior treatment are known for smokers, an adjustment was made to the SAFs to take into account the fact that these variables cannot be known for hypothetical non-smoking smokers. This adjustment is described in previous work (Miller et al., 1998a,b) .
Because the NMES did not include expenditures for nursing home care, SAEs for nursing home care were estimated by applying the SAFs for hospital expenditures for people age 65 or over to total nursing home expenditures, as in our previous studies about State Medicaid SAEs (Miller et al., 1998a) and State total SAEs (Miller et al., 1998b) . (Levit et al., 1995) . At the State level, Medicare expenditures are not available by age group. Although a small portion of Medicare expenditures are for disability payments for persons under age 65, we assumed that Medicare SAFs would not differ substantially by age. Therefore, we applied the SAF estimated for Medicare recipients age 65 or over to total Medicare expenditures for each State.
Estimation of State Medicare SAEs

Inter val Estimates
Interval estimates of Medicare SAEs were estimated by type of care for the Nation using a "jackknife" estimation (Rao, Wu, and Yue, 1992; Miller et al., 1998a) , and the relative errors from this analysis were applied to each State's estimates. Control and Prevention, 1996) . Differences in SAEs across States reflect differences in the size of the Medicare population, SAFs, and amounts spent by type of expenditure. California had the highest overall Medicare SAEs, $1.5 billion, followed by New York with $1.4 billion. Alaska had the lowest SAEs, $8 million.
RESULTS
Estimated SAFs
Estimated SAEs
Inter val Estimates
We applied the national interval estimates to each State to derive interval estimates of the State SAEs; we then aggregated these into estimated SAEs for each State. The 95-percent confidence interval ranges from $309 million to $28.0 billion. The relative error is 49.9 percent, which can be applied to the State point estimates. Table 4 shows the SAEs for Medicare, Medicaid, other public and private expenditures, and the total. In 1993, total SAEs for the Nation amounted to $72.7 billion. Of this total, SAEs for the Medicare program amounted to $14.2 billion, 19.5 percent of the total, while Medicaid SAEs amounted to $12.9 billion, 17.7 percent of the total. The remaining other public and private SAEs totaled $45.7 billion, 62.8 percent of the total. Other public programs include military and veterans' health programs, as well as State and local public programs. Private SAEs include private health insurance and out-of-pocket expenditures.
Other SAEs
There is considerable variation among the States in the source of payment for SAEs, as shown in Table 4 . Medicare SAEs in Alaska comprise only 5.4 percent of the total, while SAEs for Medicaid are 15.4 percent of the Table 5 by source of payment. The SAF for total medical expenditures was 11.83 percent, but it varied by source of payment. The Medicare SAF was the lowest, at 9.43 percent, followed by Medicaid, at 12.14 percent, and the implicit SAF for other public and private sources, at 12.75 percent.
Estimates of SAEs were updated to 1997 based on the increases in total personal health care, Medicare, and Medicaid expenditures (Levit et al., 1998) . Total expenditures are projected to $89.2 billion in 1997, with Medicare increasing to $20.5 billion, Medicaid to $17.0 billion, and other public and private sources to $51.7 billion. The proportions of care paid by Medicare and Medicaid are projected to increase slightly from 1993 to 1997, from 19.5 percent to 23.0 percent for Medicare and from 17.7 percent to 19.0 percent for Medicaid, while the proportion of care paid by other sources is projected to decrease slightly (from 62.8 to 58.0 percent).
CONCLUSIONS
This study presents State-level estimates of Medicare expenditures attributable to smoking and compares them with SAEs by other payers. The SAF for Medicare is the lowest of the three payer groups for several reasons. Prescription drugs are not covered by Medicare but were found to have a relatively high SAF in previous work. Similarly, nursing homes, which were found to have the highest SAF for total medical expenditures, are covered under Medicare only in limited circumstances. Furthermore, the sickest smokers may die before they are eligible for Medicare, and hence their costs are included in other payer groups. It is for this reason that smoking prevalence for older people in the Medicare program is lower than it is for younger adults.
The SAFs and SAEs reported here clearly show that cigarette smoking accounts for a substantial portion of annual State and national medical expenditures. There is considerable variation among the States in the proportions of Medicare, Medicaid, and other public and private medical payments attributable to smoking. The range in SAEs across States is attributable to differences in smoking prevalence, health status, and other socioeconomic variables used in the model as well as in the magnitude and patterns of medical expenditures in each State. (Miller et al., 1998a, b; Levit et al., 1998); Zhang et al., San Francisco, California, 1999 .
TECHNICAL NOTE
This Technical Note contains a detailed description of the estimation of the national model. Table A lists the variables included. The national model is based on an analysis of the NMES sample age 65 or over. Descriptive statistics for this sample are presented in Table B .
In order to address the issue of sample bias in the national model, we made the standard Heckman-Lee adjustments (Heckman, 1979; Lee, 1976) . We estimated a probit equation predicting the propensity for supplemental survey participation. We incorporated the selection-bias correction term (inverse Mill's ratios) into the morbidity equations and into the ambulatory expenditure equations of the models. Table C presents the probit results for the propensity-to-participate equations, by sex. Note that the results presented in this article are for the models that incorporate sample-bias corrections. We explored the sensitivity of the results to the omission of consideration about sample-bias correction. The results with and without the sample-bias correction were similar.
Morbidity
The morbidity portions of the model estimate the effect of smoking history on previous disease and the effect of smoking history and the propensity for previous disease on self-reported poor health status.
The propensity to have a smoking-related disease as a function of smoking history was specified, controlling for sociodemographic, economic variables, other risk factors, and an inverse Mill's ratio. We estimated a probit model of smoking-related disease propensity (Table D) . Most importantly, for both sexes, current and former smoking status (and those missing smoking information) was significantly related to an increase in the likelihood of a smoking-related disease.
Poor health is a four-categor y, selfreported health-status measure: excellent, good, fair, and poor. We used an ordered probit model (McKelvey and Zavoina, 1975) and estimated the propensity for poor health as a function of the participant's expected propensity to previously have had a smoking-related disease, conditional on whether they did or did not have any smoking-related disease, an individual's smoking history, and the control variables previously discussed. Table E presents the point estimates for this poor health propensity equation. In both sex groups, both current-smoker status and a higher propensity to have had a previous smoking-related disease increase the propensity for poor health status. For males, current smoker status reduces the variance in the propensity measure. Although being a male former smoker increased the poor health propensity, being a female former smoker had no effect on the health propensity.
Expenditures
Two Medicare expenditure equations were estimated for each of three types of medical expenditures: ambulatory, hospital, and home health care. The first equation is a probit equation estimating the propensity for positive Medicare expenditures. The second is a log expenditure equation estimating the logarithm of the magnitude of expenditures, given expenditures were positive. Table F presents point estimates for the ambulatory, hospital, and home health care propensities for positive expenditures, and Table G presents point estimates for the logarithm of positive expenditure levels for these same types of medical expenditures.
The propensity-for-poor-health variable captures the health and disease effect on expenditures caused by smoking. The smoking-history variables, controlling for poor health, capture an associative effect of smoking on expenditures. This associative effect is the resolution of some health effects not captured by the propensity for poor health and some demand effects associated with smoking. An example of a health effect not captured by the poorhealth-status model is illustrated by pregnancy. Pregnant women do not usually think of themselves as having poorer health status. Pregnancy has been found to increase the likelihood or magnitude of positive expenditures (Adams, Solanki, and Miller, 1997) . Consequently, the poorhealth measure misses increments to expenditure attributable to the effect of smoking on pregnancy. An example of a demand effect is as follows: If individuals with a smoking history do not look after their health as regularly as individuals without a smoking history, the demand of the former group for medical care and medical expenditures is lower. The direct effect of smoking history, controlling for poor health, reflects both of these behaviors and others as well.
The causal effect of smoking on expenditures, reflected by the coefficient on the health propensity in both the likelihood and the magnitude of expenditure equations is always positive and statistically significant. This is true for both the propensity and magnitude of every type of medical expenditure covered by Medicare. The associative effects vary by type of medical expenditure and by sex. For example, former male smokers have a higher likelihood of positive ambulatory expenditures, and former female smokers have a higher likelihood of positive hospital and home health care expenditures. Former male smokers have a lower magnitude of hospital expenditures, and former female smokers have a lower magnitude of home health care expenditures.
The direct-smoking-histor y variables also influence the variance in the magnitude of medical expenditures. When the effect is significant, it always increases the variance in expenditures. The estimated effects include the following: Every male history of smoking increases the variance in male ambulator y expenditures; for females, being a current smoker increases the variance in ambulatory and hospital expenditures; being a former smoker increases the variance in home health expenditures. Zhang et al., San Francisco, California, 1999. 
